Profil
Mr. Freddie Dear is a Principal at Monograph Capital Advisors (UK) LLP and a Vice President-Corporate Development at Ascend Advanced Therapies Ltd.
Mr. Dear was previously employed as a Director - Operations by Quell Therapeutics Ltd. and a Partner by Syncona Partners LLP.
He received his undergraduate degree from The University of Edinburgh.
Aktive Positionen von Freddie Dear
| Unternehmen | Position | Beginn |
|---|---|---|
Monograph Capital Advisors (UK) LLP
Monograph Capital Advisors (UK) LLP Investment ManagersFinance Monograph Capital invests in companies located in the United Kingdom. The firm targets companies operating in the fields of the biotechnology and healthcare sectors. It provides financing for early and growth stage capital requirements. | Private Equity Investor | 01.12.2021 |
Ascend Gene & Cell Therapies Ltd.
Ascend Gene & Cell Therapies Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology research and development center | Corporate Officer/Principal | 01.12.2021 |
Ehemalige bekannte Positionen von Freddie Dear
| Unternehmen | Position | Ende |
|---|---|---|
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Private Equity Investor | 01.12.2021 |
Quell Therapeutics Ltd.
Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops therapies to treat autoimmune diseases | Geschäftsführer | 31.03.2020 |
Ausbildung von Freddie Dear
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
The University of Edinburgh
The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Finance |
Quell Therapeutics Ltd.
Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops therapies to treat autoimmune diseases | Health Technology |
Monograph Capital Advisors (UK) LLP
Monograph Capital Advisors (UK) LLP Investment ManagersFinance Monograph Capital invests in companies located in the United Kingdom. The firm targets companies operating in the fields of the biotechnology and healthcare sectors. It provides financing for early and growth stage capital requirements. | Finance |
Ascend Gene & Cell Therapies Ltd.
Ascend Gene & Cell Therapies Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology research and development center | Commercial Services |
















